Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
Breast Cancer Research and Treatment
|
March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
Christian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
Archives of Gynecology and Obstetrics
|
June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
Evelyn Klein, Matthias W Beckmann, Werner Bader, et al.
Archives of Gynecology and Obstetrics
|
March 24, 2017
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network
Carlo Fremd, Carolin C Hack, Andreas Schneeweiss, et al.
Breast Care (Basel, Switzerland)
|
June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Franziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal of the National Cancer Institute
|
March 7, 2015
The contributions of breast density and common genetic variation to breast cancer risk
Celine M Vachon, V Shane Pankratz, Christopher G Scott, et al.
Geburtshilfe Und Frauenheilkunde
|
November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
BMC Cancer
|
October 16, 2024
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
Philipp Ziegler, Andreas D Hartkopf, Markus Wallwiener, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2025
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer
Laura L Michel, Philipp Ziegler, Philipp Kreis, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2024
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs
Andreas Schneeweiss, Sara Y Brucker, Hanna Huebner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 26, 2024
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
Peter A Fasching, Carolin C Hack, Naiba Nabieva, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
Breast Cancer Research and Treatment
|
March 13, 2013
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
Christian R Loehberg, Katrin Almstedt, Sebastian M Jud, et al.
Archives of Gynecology and Obstetrics
|
June 10, 2017
Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey
Evelyn Klein, Matthias W Beckmann, Werner Bader, et al.
Archives of Gynecology and Obstetrics
|
March 24, 2017
Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network
Carlo Fremd, Carolin C Hack, Andreas Schneeweiss, et al.
Breast Care (Basel, Switzerland)
|
June 29, 2018
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Franziska Würfel, Ramona Erber, Hanna Huebner, et al.
Journal of the National Cancer Institute
|
March 7, 2015
The contributions of breast density and common genetic variation to breast cancer risk
Celine M Vachon, V Shane Pankratz, Christopher G Scott, et al.
Geburtshilfe Und Frauenheilkunde
|
November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)
Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
BMC Cancer
|
October 16, 2024
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
Philipp Ziegler, Andreas D Hartkopf, Markus Wallwiener, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2025
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer
Laura L Michel, Philipp Ziegler, Philipp Kreis, et al.
Geburtshilfe Und Frauenheilkunde
|
May 31, 2024
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current Programs
Andreas Schneeweiss, Sara Y Brucker, Hanna Huebner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 26, 2024
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
Peter A Fasching, Carolin C Hack, Naiba Nabieva, et al.
Page
of 10